Pan et al. prepared a CTLA-4-PD-L1 chimeric protein vaccine and found that rats carrying intrahepatic cholangiocarcinoma had increased PD-L1 and CTLA-4 antibody titers and reduced the intrahepatic cholangiocarcinoma tumor load after receiving the vaccine 70. This evidence concerns the gene CTLA4 and neoplasm.